Akari Therapeutics
Stock Forecast, Prediction & Price Target

Akari Therapeutics Financial Estimates

Akari Therapeutics Revenue Estimates

Akari Therapeutics EBITDA Estimates

Akari Therapeutics Earnings per Share Estimates

Passed Analyst forecast
Metric 12/31/2021 12/31/2022 12/31/2023 12/31/2025 12/31/2026
Revenue
 
% change YoY
$0
 
N/A
$0
 
0%
$0
 
0%
Avg: $3.54M
Low: $3.54M
High: $3.54M
avg. 0%
Avg: $9.58M
Low: $9.58M
High: $9.58M
avg. 170.60%
Net Income
 
% change YoY
$-17.60M
 
N/A
$-6.97M
 
60.40%
$-10.00M
 
-43.54%
Avg: $-32.27M
Low: $-17.62M
High: $-17.62M
avg. -222.44%
Avg: $0
Low: $0
High: $0
avg. 100%
EBITDA
 
% change YoY
$-17.01M
 
N/A
$-28.52M
 
-67.60%
$-16.80M
 
41.08%
Avg: $0
Low: $0
High: $0
avg. 100%
Avg: $0
Low: $0
High: $0
avg. 0%
EPS
 
% change YoY
-$8.2
 
N/A
-$2.23
 
72.80%
-$2.04
 
8.52%
Avg: -$3.6
Low: -$3.6
High: -$3.6
avg. -76.47%
Avg: $0
Low: $0
High: $0
avg. 100%
Operating Expenses
 
% change YoY
$17.21M
 
N/A
$23.89M
 
38.78%
$16.80M
 
-29.65%
Avg: $0
Low: $0
High: $0
avg. -100%
Avg: $0
Low: $0
High: $0
avg. 0%

FAQ

What is Akari Therapeutics stock earnings growth forecast?

Wall Street analysts estimate the annual average earnings growth rate of -111.22% in 2025-2026.

We have gathered data from 1 analysts. Their low estimate is -17.62M, average is -32.27M and high is -17.62M.

What is Akari Therapeutics stock revenue growth forecast?

Wall Street analysts forecast annual average revenue growth of 85.30% in 2025-2026.

We have gathered data from N/A analysts. Their low revenue estimate is $3.54M, average is $3.54M and high is $3.54M.

What is Akari Therapeutics stock earnings per share growth forecast?

Wall Street analysts forecast annual average earnings growth of -38.23% in 2025-2026.

We have gathered data from 1 analysts. Their low earnings per share estimate is -$3.6, average is -$3.6 and high is $-3.6.